Skip to main content
. 2024 Jan 3;484(5):777–788. doi: 10.1007/s00428-023-03721-4

Table 2.

Antibody sources and dilutions

Antigen Pretreatment Dilution Code Number Clone Source
NapsinA (M) High pH 30 min — 96 °C 1/500 NCL-L-Napsin A IP64 Leica Biosystems
TTF-1 (M) High pH 30 min — 96 °C 1/2000 M3575 8G7G3 Dako, Agilent
p40 (M) High pH 60 min — 96 °C 1/400 API 3079 G3 BC28 Biocare Medical
Chromogranin-A (M) High pH 60 min — 98 °C 1/100 M0869 Dak-A3 Dako, Agilent
Synaptophisin (M) High pH 15 min — 96 °C 1/200 M7315 Dak-Synap Dako, Agilent
Smarca4 (M) High pH 40 min — 96 °C 1/100 sc-17796 G-7 Santa Cruz
PDL1 (M) High pH 15 min — 96 °C 1/50 SK006 22c3 Dako, Agilent
Pou2f3 (P) Low pH 15 min — 96 °C 1/200 HPA019652 Polyclonal Sigma-Aldrich
Aim2 (P) Low pH 15 min — 96 °C 1/200 HPA031365 Polyclonal Sigma-Aldrich
Foxi1 (P) High pH 30 min — 96 °C 1/500 HPA071469 Polyclonal Sigma-Aldrich

M, monoclonal; P, Polyclonal; Ki-67, Ki67 index; TTF-1, thyroid transcription factor 1; Pou2f3, POU class 2 homeobox 3; Gli1, glioma-associated oncogene family zinc finger 1; Yap1, Yes1 associated transcriptional regulator; Aim2, absent in melanoma 2; Foxi1, forkhead box I1